查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
脂肪团治疗的全球市场规模预测 (2023-2032)
市场调查报告书
商品编码
1245405

脂肪团治疗的全球市场规模预测 (2023-2032)

Global Cellulite Treatment Market Forecast 2023-2032
出版日期: | 出版商: Inkwood Research | 英文 232 Pages | 商品交期: 2-3个工作天内

价格

在 2023 年至 2032 年的预测期内，全球脂肪团治疗市场规模预计将以 9.44% 的复合年增长率增长。 推动市场的因素包括对美容和整容手术的需求增加、肥胖病例增加以及医疗旅游业的快速增长。

本报告考察了全球脂肪团治疗市场，提供了市场概况和趋势、市场驱动因素和製约因素、按细分市场和地区划分的市场分析、竞争格局以及主要参与者的概况，并提供了系统信息。

内容

第一章研究范围与研究方法

  • 调查目的
  • 调查方法
  • 先决条件和限制

第 2 章执行摘要

  • 市场规模和估计
  • 市场概览
  • 调查范围
  • 危机情景分析
  • 主要市场调查结果
    • 审美意识增强
    • 越来越偏爱非侵入性手术
    • 技术进步推动市场增长
    • 生活方式的突然改变导致肥胖

第三章市场动态

  • 关键驱动因素
    • 对美容和美容护理的需求不断增长
    • 肥胖增加
    • 医疗旅游业的快速增长
  • 主要製约因素
    • 高级橘皮组织治疗费用高昂
    • 治疗后的副作用
    • 缺乏意识

第四章重点分析

  • 母市场分析
  • 主要技术趋势
  • 波特的五力分析
    • 买方的权力
    • 供应商公司的权力
    • 备选方案
    • 新人
    • 行业竞争
  • 增长前景图
  • 市场成熟度分析
  • 市场集中度分析
  • 价值链分析
    • 研究与开发
    • 产品开发
    • 营销和分销
    • 售后监控
  • 主要采购标准
    • 费用
    • 品牌声誉
    • 易于使用

第 5 章治疗市场

  • 非侵入性
  • 微创
  • 本地

第 6 章市场类型

  • 柔软的橘皮组织
  • 硬脂肪团
  • 水肿橘皮组织

第 7 章最终用户市场

  • 医院
  • 诊所和美容中心
  • 其他最终用户

第八章区域分析

  • 北美
    • 市场规模和估计
    • 司机
    • 任务
    • 监管框架
    • 主要公司
    • 国家分析
  • 欧洲
    • 市场规模和估计
    • 司机
    • 任务
    • 监管框架
    • 主要公司
    • 国家分析
  • 亚太地区
    • 市场规模和估计
    • 司机
    • 任务
    • 监管框架
    • 主要公司
    • 国家分析
  • 世界其他地方
    • 市场规模和估计
    • 司机
    • 任务
    • 监管框架
    • 主要公司
    • 区域分析

第9章竞争格局

  • 重大战略发展
    • 收购
    • 产品发布和开发
    • 合作伙伴关係和合同
    • 扩张和销售
  • 公司简介
    • ABBVIE INC
    • ALMA LASERS
    • BAUSCH HEALTH COMPANIES INC.
    • CANDELA CORPORATION
    • CUTERA INC
    • CYNOSURE LLC
    • ENDO INTERNATIONAL PLC
    • GALDERMA SA
    • INCELER MEDIKAL CO LTD
    • JOHNSON & JOHNSON
    • MERZ PHARMA GMBH & CO KGAA
    • NUBWAY CO LTD
    • SIENTRA INC
    • SINCLAIR PHARMA
    • ZIMMER MEDIZINSYSTEME
Product Code: 50829

KEY FINDINGS

The global cellulite treatment market is anticipated to register a CAGR of 9.44% during the forecast period 2023-2032. Some of the key drivers facilitating the market's growth include the increasing demand for aesthetic and cosmetic procedures, rising cases of obesity, as well as the rapidly booming medical tourism industry.

MARKET INSIGHTS

Cellulite is characterized as fat collections that push against the connective tissue beneath the skin. It appears on the stomach, buttocks, and thighs. Cellulite may be caused due to accumulated toxins, poor diet, genetics, pregnancy, weight gain, and inactivity.

Obesity is one of the leading health concerns globally. Obesity leads to cellulite by virtue of heightening the volume of fat trapped within irregular-sized fat lobules. According to the Centers for Disease Control and Prevention (CDC), obesity prevalence in the United States was more than 41% in 2017. Furthermore, according to the World Health Organization (WHO), approximately 39 million children under the age of 5 were obese or overweight in the year 2020. People with obesity are more vulnerable to health issues like cardiac disorders, diabetes, high blood pressure, strokes, and other conditions. Such health problems encourage individuals to undergo treatment for obesity, thereby facilitating the global cellulite treatment market growth.

REGIONAL INSIGHTS

The global cellulite treatment market growth analysis covers a detailed assessment of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR during the forecast period. The regional market's growth is primarily ascribed to the presence of skilled professionals and high-quality healthcare facilities, in addition to the lower cost of treatments and premium healthcare services.

COMPETITIVE INSIGHTS

The degree of industrial rivalry within the global cellulite treatment market is projected to be high during the forecast period. Some of the key companies operating in the market are: Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation caters to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW
  • 2.3. SCOPE OF STUDY
  • 2.4. CRISIS SCENARIO ANALYSIS
  • 2.5. MAJOR MARKET FINDINGS
    • 2.5.1. RISING BEAUTY CONSCIOUSNESS
    • 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
    • 2.5.3. TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
    • 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
    • 3.1.2. RISING CASES OF OBESITY
    • 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
    • 3.2.2. SIDE EFFECTS POST-TREATMENT
    • 3.2.3. LACK OF AWARENESS

4. KEY ANALYTICS

  • 4.1. PARENT MARKET ANALYSIS
  • 4.2. KEY TECHNOLOGY TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. GROWTH PROSPECT MAPPING
  • 4.5. MARKET MATURITY ANALYSIS
  • 4.6. MARKET CONCENTRATION ANALYSIS
  • 4.7. VALUE CHAIN ANALYSIS
    • 4.7.1. RESEARCH AND DEVELOPMENT
    • 4.7.2. PRODUCT DEVELOPMENT
    • 4.7.3. MARKETING AND DISTRIBUTION
    • 4.7.4. POST-SALES MONITORING
  • 4.8. KEY BUYING CRITERIA
    • 4.8.1. COST
    • 4.8.2. BRAND REPUTATION
    • 4.8.3. USABILITY

5. MARKET BY PROCEDURE

  • 5.1. NON-INVASIVE
  • 5.2. MINIMALLY INVASIVE
  • 5.3. TOPICAL

6. MARKET BY TYPE

  • 6.1. SOFT CELLULITE
  • 6.2. HARD CELLULITE
  • 6.3. EDEMATOUS CELLULITE

7. MARKET BY END-USER

  • 7.1. HOSPITALS
  • 7.2. CLINICS AND BEAUTY CENTERS
  • 7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
    • 8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
    • 8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
    • 8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
    • 8.1.6. COUNTRY ANALYSIS
      • 8.1.6.1. UNITED STATES
      • 8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.1.6.2. CANADA
      • 8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
    • 8.2.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
    • 8.2.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
    • 8.2.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
    • 8.2.6. COUNTRY ANALYSIS
      • 8.2.6.1. UNITED KINGDOM
      • 8.2.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.2. GERMANY
      • 8.2.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.3. FRANCE
      • 8.2.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.4. ITALY
      • 8.2.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.5. BELGIUM
      • 8.2.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.6. POLAND
      • 8.2.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.2.6.7. REST OF EUROPE
      • 8.2.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  • 8.3. ASIA-PACIFIC
    • 8.3.1. MARKET SIZE & ESTIMATES
    • 8.3.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
    • 8.3.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
    • 8.3.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
    • 8.3.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
    • 8.3.6. COUNTRY ANALYSIS
      • 8.3.6.1. CHINA
      • 8.3.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.2. JAPAN
      • 8.3.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.3. INDIA
      • 8.3.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.4. SOUTH KOREA
      • 8.3.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.5. THAILAND
      • 8.3.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.6. INDONESIA
      • 8.3.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.7. VIETNAM
      • 8.3.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.8. AUSTRALIA & NEW ZEALAND
      • 8.3.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.3.6.9. REST OF ASIA-PACIFIC
      • 8.3.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. REST OF WORLD CELLULITE TREATMENT MARKET DRIVERS
    • 8.4.3. REST OF WORLD CELLULITE TREATMENT MARKET CHALLENGES
    • 8.4.4. REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
    • 8.4.5. KEY PLAYERS IN REST OF WORLD CELLULITE TREATMENT MARKET
    • 8.4.6. REGIONAL ANALYSIS
      • 8.4.6.1. LATIN AMERICA
      • 8.4.6.1.1. LATIN AMERICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
      • 8.4.6.2. MIDDLE EAST & AFRICA
      • 8.4.6.2.1. MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. EXPANSIONS & DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. ABBVIE INC
      • 9.2.1.1. COMPANY OVERVIEW
      • 9.2.1.2. FINANCIAL ANALYSIS
      • 9.2.1.3. PRODUCTS / SERVICES LIST
      • 9.2.1.4. STRENGTHS & CHALLENGES
    • 9.2.2. ALMA LASERS
      • 9.2.2.1. COMPANY OVERVIEW
      • 9.2.2.2. PRODUCTS / SERVICES LIST
    • 9.2.3. BAUSCH HEALTH COMPANIES INC.
      • 9.2.3.1. COMPANY OVERVIEW
      • 9.2.3.2. FINANCIAL ANALYSIS
      • 9.2.3.3. PRODUCTS / SERVICES LIST
      • 9.2.3.4. STRENGTHS & CHALLENGES
    • 9.2.4. CANDELA CORPORATION
      • 9.2.4.1. COMPANY OVERVIEW
      • 9.2.4.2. PRODUCTS / SERVICES LIST
      • 9.2.4.3. STRENGTHS & CHALLENGES
    • 9.2.5. CUTERA INC
      • 9.2.5.1. COMPANY OVERVIEW
      • 9.2.5.2. FINANCIAL ANALYSIS
      • 9.2.5.3. PRODUCTS / SERVICES LIST
      • 9.2.5.4. STRENGTHS & CHALLENGES
    • 9.2.6. CYNOSURE LLC
      • 9.2.6.1. COMPANY OVERVIEW
      • 9.2.6.2. PRODUCTS / SERVICES LIST
      • 9.2.6.3. STRENGTHS & CHALLENGES
    • 9.2.7. ENDO INTERNATIONAL PLC
      • 9.2.7.1. COMPANY OVERVIEW
      • 9.2.7.2. FINANCIAL ANALYSIS
      • 9.2.7.3. PRODUCTS / SERVICES LIST
      • 9.2.7.4. STRENGTHS & CHALLENGES
    • 9.2.8. GALDERMA SA
      • 9.2.8.1. COMPANY OVERVIEW
      • 9.2.8.2. PRODUCTS / SERVICES LIST
      • 9.2.8.3. STRENGTHS & CHALLENGES
    • 9.2.9. INCELER MEDIKAL CO LTD
      • 9.2.9.1. COMPANY OVERVIEW
      • 9.2.9.2. PRODUCTS / SERVICES LIST
      • 9.2.9.3. STRENGTHS & CHALLENGES
    • 9.2.10. JOHNSON & JOHNSON
      • 9.2.10.1. COMPANY OVERVIEW
      • 9.2.10.2. FINANCIAL ANALYSIS
      • 9.2.10.3. PRODUCTS / SERVICES LIST
      • 9.2.10.4. STRENGTHS & CHALLENGES
    • 9.2.11. MERZ PHARMA GMBH & CO KGAA
      • 9.2.11.1. COMPANY OVERVIEW
      • 9.2.11.2. PRODUCTS / SERVICES LIST
      • 9.2.11.3. STRENGTHS & CHALLENGES
    • 9.2.12. NUBWAY CO LTD
      • 9.2.12.1. COMPANY OVERVIEW
      • 9.2.12.2. PRODUCTS / SERVICES LIST
    • 9.2.13. SIENTRA INC
      • 9.2.13.1. COMPANY OVERVIEW
      • 9.2.13.2. FINANCIAL ANALYSIS
      • 9.2.13.3. PRODUCTS / SERVICES LIST
      • 9.2.13.4. STRENGTHS & CHALLENGES
    • 9.2.14. SINCLAIR PHARMA
      • 9.2.14.1. COMPANY OVERVIEW
      • 9.2.14.2. PRODUCTS / SERVICES LIST
    • 9.2.15. ZIMMER MEDIZINSYSTEME
      • 9.2.15.1. COMPANY OVERVIEW
      • 9.2.15.2. PRODUCTS / SERVICES LIST
      • 9.2.15.3. STRENGTHS & CHALLENGES

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CELLULITE TREATMENT
  • TABLE 2: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 3: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 4: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 5: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 6: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 7: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 8: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 9: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 12: GLOBAL SOFT CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 13: GLOBAL SOFT CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 14: GLOBAL HARD CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 15: GLOBAL HARD CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 16: GLOBAL EDEMATOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 17: GLOBAL EDEMATOUS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 18: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 19: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 21: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 22: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 23: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 25: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 26: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 27: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 28: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 29: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 30: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
  • TABLE 31: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
  • TABLE 32: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 33: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 34: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
  • TABLE 35: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
  • TABLE 36: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 37: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 38: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
  • TABLE 39: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
  • TABLE 40: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
  • TABLE 41: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
  • TABLE 42: REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
  • TABLE 43: LEADING PLAYERS OPERATING IN REST OF WORLD CELLULITE TREATMENT MARKET
  • TABLE 44: LIST OF ACQUISITIONS
  • TABLE 45: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 46: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 47: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY TECHNOLOGY TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: GROWTH PROSPECT MAPPING
  • FIGURE 4: MARKET MATURITY ANALYSIS
  • FIGURE 5: MARKET CONCENTRATION ANALYSIS
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
  • FIGURE 9: GLOBAL CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
  • FIGURE 10: GLOBAL CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
  • FIGURE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
  • FIGURE 12: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
  • FIGURE 13: GLOBAL CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
  • FIGURE 14: GLOBAL CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
  • FIGURE 15: GLOBAL CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
  • FIGURE 16: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
  • FIGURE 17: GLOBAL CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
  • FIGURE 18: GLOBAL CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
  • FIGURE 19: GLOBAL CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 23: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 24: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 25: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 26: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 27: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 28: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 29: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 30: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 31: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
  • FIGURE 32: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 33: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 34: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 35: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 36: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 37: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 38: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 39: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 40: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 41: REST OF WORLD CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
  • FIGURE 42: LATIN AMERICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 43: MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
  • FIGURE 44: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
  • FIGURE 45: ABBVIE INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
  • FIGURE 46: ABBVIE INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
  • FIGURE 47: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
  • FIGURE 48: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
  • FIGURE 49: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
  • FIGURE 50: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
  • FIGURE 51: CUTERA INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
  • FIGURE 52: CUTERA INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
  • FIGURE 53: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
  • FIGURE 54: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
  • FIGURE 55: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
  • FIGURE 56: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
  • FIGURE 57: JOHNSON & JOHNSON COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
  • FIGURE 58: JOHNSON & JOHNSON COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
  • FIGURE 59: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
  • FIGURE 60: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)